Pomalidomide 2mg tablet is an oral medicine used to treat a couple of myeloma, a form of cancer that impacts the bone marrow. It belongs to a class of medication referred to as immunomodulatory dealers, which work by way of modifying the immune system's response to cancer cells. Pomalidomide is especially indicated for patients who have received as a minimum previous treatment plans, inclusive of lenalidomide and a proteasome inhibitor, and feature validated disease progression.